Bridget E. Bunner

Array ( [id] => 1020854 [patent_doc_number] => 06887477 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 09/762188 [patent_app_country] => US [patent_app_date] => 1999-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 9725 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887477.pdf [firstpage_image] =>[orig_patent_app_number] => 09762188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460577 [patent_doc_number] => 06392019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Antibodies specific for EGF motif proteins' [patent_app_type] => B1 [patent_app_number] => 09/363316 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 32682 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/392/06392019.pdf [firstpage_image] =>[orig_patent_app_number] => 09363316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486806 [patent_doc_number] => 06428781 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Composition of an endogenous insulin-like growth factor-II derivative' [patent_app_type] => B1 [patent_app_number] => 09/331851 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 12854 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428781.pdf [firstpage_image] =>[orig_patent_app_number] => 09331851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730125 [patent_doc_number] => 20030186315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'ADMINISTRATION OF AN AGENT WHICH DECREASES PROCESSING OF AMYLOID PRECURSOR PROTEIN' [patent_app_type] => new [patent_app_number] => 09/297877 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5970 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186315.pdf [firstpage_image] =>[orig_patent_app_number] => 09297877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357891 [patent_doc_number] => 06573095 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Polynucleotides isolated from skin cells' [patent_app_type] => B1 [patent_app_number] => 09/312283 [patent_app_country] => US [patent_app_date] => 1999-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 80070 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573095.pdf [firstpage_image] =>[orig_patent_app_number] => 09312283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1205133 [patent_doc_number] => 06716576 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Method of assaying Neutrokine- mRNA level' [patent_app_type] => B1 [patent_app_number] => 09/255794 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 78217 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716576.pdf [firstpage_image] =>[orig_patent_app_number] => 09255794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1592733 [patent_doc_number] => 06383480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells' [patent_app_type] => B1 [patent_app_number] => 09/214569 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6097 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383480.pdf [firstpage_image] =>[orig_patent_app_number] => 09214569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071566 [patent_doc_number] => 06841147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-11 [patent_title] => 'Stem cell factor compositions' [patent_app_type] => utility [patent_app_number] => 09/224683 [patent_app_country] => US [patent_app_date] => 1998-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 99 [patent_no_of_words] => 50986 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841147.pdf [firstpage_image] =>[orig_patent_app_number] => 09224683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040313 [patent_doc_number] => 06869609 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => 'Method for treatment of renal failure and occlusive lesion of blood vessels by administration of hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 09/555629 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 5067 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869609.pdf [firstpage_image] =>[orig_patent_app_number] => 09555629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1085538 [patent_doc_number] => 06830882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-14 [patent_title] => 'Method of testing compounds for regulation of transcription of peroxisome proliferator activated receptorgamma' [patent_app_type] => B1 [patent_app_number] => 09/155252 [patent_app_country] => US [patent_app_date] => 1998-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8498 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/830/06830882.pdf [firstpage_image] =>[orig_patent_app_number] => 09155252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463195 [patent_doc_number] => 06350856 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Cytokine suppressive anti-inflammatory drug binding protein' [patent_app_type] => B1 [patent_app_number] => 09/047288 [patent_app_country] => US [patent_app_date] => 1998-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 10349 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350856.pdf [firstpage_image] =>[orig_patent_app_number] => 09047288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 724771 [patent_doc_number] => 07045531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-16 [patent_title] => 'Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator' [patent_app_type] => utility [patent_app_number] => 09/380704 [patent_app_country] => US [patent_app_date] => 1998-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 60 [patent_no_of_words] => 40750 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045531.pdf [firstpage_image] =>[orig_patent_app_number] => 09380704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1235383 [patent_doc_number] => 06689579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Polynucleotides encoding neutrokine- ' [patent_app_type] => B1 [patent_app_number] => 09/005874 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27990 [patent_no_of_claims] => 194 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689579.pdf [firstpage_image] =>[orig_patent_app_number] => 09005874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032020 [patent_doc_number] => 20020018763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'A METHOD OF STIMULATING GROWTH OF STROMAL CELLS WITH STEM CELL FACTOR (SCF) POLYPEPTIDES' [patent_app_type] => new [patent_app_number] => 09/005243 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 119 [patent_no_of_words] => 52519 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018763.pdf [firstpage_image] =>[orig_patent_app_number] => 09005243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531863 [patent_doc_number] => 06410268 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Polynucleotides encoding chemokine alpha-3' [patent_app_type] => B1 [patent_app_number] => 08/816772 [patent_app_country] => US [patent_app_date] => 1997-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19845 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410268.pdf [firstpage_image] =>[orig_patent_app_number] => 08816772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024039 [patent_doc_number] => 06884411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-26 [patent_title] => 'Method of treating viral hepatitis by administration of liquid human α-interferon' [patent_app_type] => utility [patent_app_number] => 09/125122 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4122 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884411.pdf [firstpage_image] =>[orig_patent_app_number] => 09125122 [rel_patent_id] =>[rel_patent_doc_number] =>)